CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Philip Boudreau

Chief Financial Officer & Executive Vice President of Finance, Abbott Laboratories

Verified interview transcripts, podcast appearances, and direct quotes from Philip Boudreau, Chief Financial Officer & Executive Vice President of Finance at Abbott Laboratories. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • $ABT Abbott Laboratories Q2 2026 Earnings Conference Call

    July 16, 2026 · 📺 EARNMOAR

    07/16/2026 Q&A: 13:55 Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Meniere…

    Watch on YouTube ↗

  • $ABT Abbott Laboratories Q1 2026 Earnings Conference Call

    April 16, 2026 · 📺 EARNMOAR

    04/16/2026 Q&A: 13:48 Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Meniere…

    Watch on YouTube ↗

  • $ABT Abbott Labs Q4 2025 Earnings Conference Call

    January 22, 2026 · 📺 EARNMOAR

    01/22/2026 Q&A: 15:14 Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Menie…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →